Advertisement
Screener

PAR PHARMACEUTICAL COMPANIES, INC. Increase (Decrease) in Inventories

PAR PHARMACEUTICAL COMPANIES, INC. Increase (Decrease) in Inventories

PAR PHARMACEUTICAL COMPANIES, INC. reported Increase (Decrease) in Inventories of $23.55 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2015-08-06

  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for the quarter ending 2015-06-30 was $12.11M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for the quarter ending 2015-03-31 was $11.44M, a 45.47% decline year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for the quarter ending 2014-09-30 was $5.84M, a 58.29% increase year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for the quarter ending 2014-06-30 was -$6.53M, a 436.51% decline year-over-year.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for fiscal 2011 was $12.19M.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for fiscal 2010 was -$8.15M, a 122.38% decline from fiscal 2009.
  • PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in inventories for fiscal 2009 was $36.40M.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2015-06-30$12.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$23.55M
10-Q · filed 2015-08-06
2015-03-31$11.44M
10-Q · filed 2015-05-11
2014-09-30$5.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
-$689.00K
derived: sum of 2 quarters · filed 2015-08-06
$20.30M
10-Q · filed 2014-11-12
2014-06-30-$6.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$14.46M
10-Q · filed 2015-08-06
2014-03-31$20.98M
10-Q · filed 2015-05-11
2013-09-30$3.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$5.63M
derived: sum of 2 quarters · filed 2014-11-12
$21.20M
10-Q · filed 2014-11-12
2013-06-30$1.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$17.51M
10-Q · filed 2014-08-11
2013-03-31$15.57M
10-Q · filed 2014-05-15
2012-06-30-$3.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$17.20M
10-Q · filed 2012-08-02
-$13.41M
derived: sum of 3 quarters · filed 2012-08-02
-$7.78M
derived: sum of 4 quarters · filed 2012-08-02
2012-03-31-$13.65M
10-Q · filed 2012-05-08
-$9.86M
derived: sum of 2 quarters · filed 2012-05-08
-$4.23M
derived: sum of 3 quarters · filed 2012-05-08
$1.45M
derived: sum of 4 quarters · filed 2012-08-02
2011-12-31$3.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$9.42M
derived: sum of 2 quarters · filed 2012-02-28
$15.09M
derived: sum of 3 quarters · filed 2012-08-02
$12.19M
10-K · filed 2012-02-28
2011-09-30$5.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$11.31M
derived: sum of 2 quarters · filed 2012-08-02
$8.41M
10-Q · filed 2011-11-02
$4.32M
derived: sum of 4 quarters · filed 2012-08-02
2011-06-30$5.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
$2.77M
10-Q · filed 2012-08-02
-$1.31M
derived: sum of 3 quarters · filed 2012-08-02
$6.53M
derived: sum of 4 quarters · filed 2012-08-02
2011-03-31-$2.90M
10-Q · filed 2012-05-08
-$6.98M
derived: sum of 2 quarters · filed 2012-05-08
$858.00K
derived: sum of 3 quarters · filed 2012-05-08
$2.40M
derived: sum of 4 quarters · filed 2012-05-08
2010-12-31-$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$3.76M
derived: sum of 2 quarters · filed 2012-02-28
$5.30M
derived: sum of 3 quarters · filed 2012-02-28
-$8.15M
10-K · filed 2012-02-28
2010-09-30$7.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$9.39M
derived: sum of 2 quarters · filed 2011-11-02
-$4.07M
10-Q · filed 2011-11-02
2010-06-30$1.55M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-08-03
-$11.91M
10-Q · filed 2011-08-03
2010-03-31-$13.45M
10-Q/A · filed 2011-05-06
2009-12-31$36.40M
10-K · filed 2012-02-28